These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24911240)

  • 1. Success of measles virotherapy in ATL depends on type I interferon secretion and responsiveness.
    M Parrula MC; Fernandez SA; Landes K; Huey D; Lairmore M; Niewiesk S
    Virus Res; 2014 Aug; 189():206-13. PubMed ID: 24911240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles virotherapy in a mouse model of adult T-cell leukaemia/lymphoma.
    Parrula C; Fernandez SA; Zimmerman B; Lairmore M; Niewiesk S
    J Gen Virol; 2011 Jun; 92(Pt 6):1458-1466. PubMed ID: 21325484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia.
    Betancourt D; Ramos JC; Barber GN
    J Virol; 2015 Dec; 89(23):11786-800. PubMed ID: 26378177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
    Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF
    Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy.
    Li H; Peng KW; Dingli D; Kratzke RA; Russell SJ
    Cancer Gene Ther; 2010 Aug; 17(8):550-8. PubMed ID: 20379224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tumor invasion factors determines systemic engraftment and induction of humoral hypercalcemia in a mouse model of adult T-cell leukemia.
    Parrula C; Zimmerman B; Nadella P; Shu S; Rosol T; Fernandez S; Lairmore M; Niewiesk S
    Vet Pathol; 2009 Sep; 46(5):1003-14. PubMed ID: 19429977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the Type I Interferon Response Defines the Sensitivity of Human Melanoma Cells to Oncolytic Measles Virus.
    Allagui F; Achard C; Panterne C; Combredet C; Labarrière N; Dréno B; Elgaaied AB; Pouliquen D; Tangy F; Fonteneau JF; Grégoire M; Boisgerault N
    Curr Gene Ther; 2017; 16(6):419-428. PubMed ID: 28042780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of type I interferon secretion through recombinant Newcastle disease virus expressing measles virus hemagglutinin stimulates antibody secretion in the presence of maternal antibodies.
    Kim D; Martinez-Sobrido L; Choi C; Petroff N; García-Sastre A; Niewiesk S; Carsillo T
    J Virol; 2011 Jan; 85(1):200-7. PubMed ID: 20962092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
    Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
    Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of novel histone deacetylase inhibitor, AR42, in a mouse model of, human T-lymphotropic virus type 1 adult T cell lymphoma.
    Zimmerman B; Sargeant A; Landes K; Fernandez SA; Chen CS; Lairmore MD
    Leuk Res; 2011 Nov; 35(11):1491-7. PubMed ID: 21802726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
    Kurokawa C; Iankov ID; Anderson SK; Aderca I; Leontovich AA; Maurer MJ; Oberg AL; Schroeder MA; Giannini C; Greiner SM; Becker MA; Thompson EA; Haluska P; Jentoft ME; Parney IF; Weroha SJ; Jen J; Sarkaria JN; Galanis E
    J Natl Cancer Inst; 2018 Oct; 110(10):1123-1132. PubMed ID: 29788332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor activity of 5-aminoimidazole-4-carboxamide riboside with AMPK-independent cell death in human adult T-cell leukemia/lymphoma.
    Aikawa A; Kozako T; Kato N; Ohsugi T; Honda SI
    Eur J Pharmacol; 2023 Dec; 961():176180. PubMed ID: 37956732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus.
    Aref S; Castleton AZ; Bailey K; Burt R; Dey A; Leongamornlert D; Mitchell RJ; Okasha D; Fielding AK
    Mol Ther; 2020 Apr; 28(4):1043-1055. PubMed ID: 32087150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment.
    Chatelain C; Berland L; Grard M; Jouand N; Fresquet J; Nader J; Hirigoyen U; Petithomme T; Combredet C; Pons-Tostivint E; Fradin D; Treps L; Blanquart C; Boisgerault N; Tangy F; Fonteneau JF
    Oncoimmunology; 2024; 13(1):2377830. PubMed ID: 39005546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Type I Interferon Production by Human T-Cell Leukemia Virus Type 1 Oncoprotein Tax through Inhibition of IRF3 Phosphorylation.
    Yuen CK; Chan CP; Fung SY; Wang PH; Wong WM; Tang HV; Yuen KS; Chan CP; Jin DY; Kok KH
    J Virol; 2016 Apr; 90(8):3902-3912. PubMed ID: 26819312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral hypercalcemia of malignancy: severe combined immunodeficient/beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 tax expression.
    Richard V; Lairmore MD; Green PL; Feuer G; Erbe RS; Albrecht B; D'Souza C; Keller ET; Dai J; Rosol TJ
    Am J Pathol; 2001 Jun; 158(6):2219-28. PubMed ID: 11395400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of T cells as carriers for systemic measles virotherapy in the presence of antiviral antibodies.
    Ong HT; Hasegawa K; Dietz AB; Russell SJ; Peng KW
    Gene Ther; 2007 Feb; 14(4):324-33. PubMed ID: 17051248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.
    Niewiesk S
    ILAR J; 2016; 57(1):3-11. PubMed ID: 27034390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engraftment and tumorigenesis of HTLV-1 transformed T cell lines in SCID/bg and NOD/SCID mice.
    Liu Y; Dole K; Stanley JR; Richard V; Rosol TJ; Ratner L; Lairmore M; Feuer G
    Leuk Res; 2002 Jun; 26(6):561-7. PubMed ID: 12007504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.